HSIC (Henry Schein) 3-Month Share Buyback Ratio : 1.54% (As of Mar. 2025 )

View and export this data going back to 1995. Start your Free Trial

What is Henry Schein 3-Month Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Henry Schein's current 3-Month Share Buyback Ratio was 1.54%.

Competitive Comparison of Henry Schein's 3-Month Share Buyback Ratio

For the Medical Distribution subindustry, Henry Schein's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Henry Schein's 3-Month Share Buyback Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Henry Schein's 3-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Henry Schein's 3-Month Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Henry Schein 3-Month Share Buyback Ratio Calculation

Henry Schein's 3-Month Share Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

3-Month Share Buyback Ratio	=	(Shares Outstanding (EOP) (Dec. 2024 )	-	Shares Outstanding (EOP) (Mar. 2025 ))	/	Shares Outstanding (EOP) (Dec. 2024 )
	=	(124.156	-	122.244)	/	124.156
	=	1.54%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henry Schein (NAS:HSIC) 3-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Henry Schein 3-Month Share Buyback Ratio Related Terms

Henry Schein Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Henry Schein Inc (NAS:HSIC) » Definitions » 3-Month Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

0L3C:UK HS2:Germany HS2:Germany H1SI34:Brazil HSIC:Austria

Address

135 Duryea Road, Melville, NY, USA, 11747

Website

https://www.henryschein.com

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

Executives

Bradford C Connett	officer: CEO, NA Distribution Group	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Philip A Laskawy	director	9 CREAMER HILL ROAD, GREENWICH CT 06831
Kurt P Kuehn	director	C/O HENRY SCHEIN, INC, 135 DURYEA ROAD, MELVILLE NY 11747
Michael S Ettinger	officer: SVP, General Counsel, Sec.	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Lorelei Mcglynn	officer: SVP, Global HR & Fin. Oper.	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Mark E Mlotek	director, officer: SVP, Corp Bus Dev Group	C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747
Walter Siegel	officer: Senior VP & General Counsel	C/O HENRY SCHEIN, INC, 135 DURYEA RD, MELVILLE NY 11747
James P Breslawski	director, officer: Executive Vice President	C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747
Stanley M Bergman	director, officer: President and CEO	C/O HENRY SCHEIN INC, 135 DURYEA ROAD, MELVILLE NY 11747
Brous David B Jr	officer: CEO, Strategic Business Group	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Gerald A Benjamin	director, officer: Executive V.P and CAO	C/O HENRY SCHEIN, INC, 135 DURYEA RD, MELVILLE NY 11747
Ronald N. South	officer: SVP & Chief Financial Officer	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Scott Philip Serota	director	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Reed Vaughn Tuckson	director	C/O UNITEDHEALTH GROUP INCORPORATED, 9900 BREN ROAD EAST, MINNETONKA MN 55123
Steven Paladino	director, officer: Executive V.P. and CFO	C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747